| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.57B | 73.21B | 72.20B | 70.44B | 67.21B | 64.88B |
| Gross Profit | 38.49B | 38.26B | 37.53B | 35.72B | 33.52B | 33.39B |
| EBITDA | 3.87B | 3.63B | 3.98B | -550.00M | 2.96B | 623.00M |
| Net Income | 1.21B | 1.03B | 1.40B | -3.04B | 736.00M | -1.15B |
Balance Sheet | ||||||
| Total Assets | 31.32B | 31.07B | 30.19B | 28.94B | 31.65B | 32.01B |
| Cash, Cash Equivalents and Short-Term Investments | 8.01B | 7.94B | 7.94B | 7.52B | 9.41B | 7.92B |
| Total Debt | 8.98B | 7.25B | 7.46B | 6.74B | 8.80B | 9.01B |
| Total Liabilities | 20.37B | 20.18B | 20.08B | 20.24B | 19.92B | 21.04B |
| Stockholders Equity | 10.90B | 10.85B | 10.03B | 8.63B | 11.63B | 10.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.18B | 3.50B | 2.50B | 2.46B | -597.00M |
| Operating Cash Flow | 0.00 | 3.84B | 3.55B | 2.52B | 2.58B | -538.00M |
| Investing Cash Flow | 0.00 | -1.94B | -2.49B | -1.15B | 306.00M | -604.00M |
| Financing Cash Flow | 0.00 | -1.91B | -644.00M | -3.27B | -1.40B | 3.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥51.40B | 11.04 | ― | 2.41% | 6.49% | 4.27% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥48.73B | 74.59 | ― | 1.30% | 2.90% | -26.37% | |
59 Neutral | ¥307.07B | 75.07 | ― | 0.56% | 9.28% | 7.59% | |
58 Neutral | ¥77.80B | -50.43 | ― | 0.32% | 0.51% | 4.92% | |
58 Neutral | ¥142.17B | 31.47 | ― | 0.63% | 4.32% | 11.78% | |
53 Neutral | ¥203.70B | 72.52 | ― | 0.69% | 10.75% | -14.28% |